OBJECTIVE: The purpose was to investigate single nucleotide polymorphism of the vitamin D receptor gene and its possible relationship with colorectal cancer (CRC) in a Chinese population. METHODS: The vitamin D receptor (VDR) genotypes were determined by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) using endonuclease BsmI and FokI, and direct sequencing in 400 Chinese people, comprised of 200 CRC patients and 200 controls from the same area in China. RESULTS: The distribution of alleles (F/f) and genotypes (FF/Ff/ff) of the FokI had no significant difference between CRC patients and normal controls (P > 0.05), while that of the B allele and the BB genotype of the BsmI in CRC patients was significantly lower compared with the control group (0.1625 versus 0.740, P < 0.05, OR = 0.068, 95% CI: 0.048-0.096 and 0.060 versus 0.590, P < 0.05, OR = 0.015, 95% CI: 0.007-0.032). CONCLUSION: The BB genotype of the VDR BsmI variant was significantly associated with a decreased risk of CRC in a Chinese population, while the VDR FokI polymorphism was not significantly associated with it.
OBJECTIVE: The purpose was to investigate single nucleotide polymorphism of the vitamin D receptor gene and its possible relationship with colorectal cancer (CRC) in a Chinese population. METHODS: The vitamin D receptor (VDR) genotypes were determined by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) using endonuclease BsmI and FokI, and direct sequencing in 400 Chinese people, comprised of 200 CRC patients and 200 controls from the same area in China. RESULTS: The distribution of alleles (F/f) and genotypes (FF/Ff/ff) of the FokI had no significant difference between CRC patients and normal controls (P > 0.05), while that of the B allele and the BB genotype of the BsmI in CRC patients was significantly lower compared with the control group (0.1625 versus 0.740, P < 0.05, OR = 0.068, 95% CI: 0.048-0.096 and 0.060 versus 0.590, P < 0.05, OR = 0.015, 95% CI: 0.007-0.032). CONCLUSION: The BB genotype of the VDR BsmI variant was significantly associated with a decreased risk of CRC in a Chinese population, while the VDR FokI polymorphism was not significantly associated with it.
Authors: Maureen A Murtaugh; Carol Sweeney; Khe-Ni Ma; John D Potter; Bette J Caan; Roger K Wolff; Martha L Slattery Journal: Nutr Cancer Date: 2006 Impact factor: 2.900
Authors: Pia Sillanpää; Ari Hirvonen; Vesa Kataja; Matti Eskelinen; Veli-Matti Kosma; Matti Uusitupa; Harri Vainio; Katja Mitrunen Journal: Pharmacogenetics Date: 2004-04
Authors: Sonia M Boyapati; Roberd M Bostick; Katherine A McGlynn; Michael F Fina; Walter M Roufail; Kim R Geisinger; Michael Wargovich; Ann Coker; James R Hebert Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-07 Impact factor: 4.254
Authors: H G Pálmer; J M González-Sancho; J Espada; M T Berciano; I Puig; J Baulida; M Quintanilla; A Cano; A G de Herreros; M Lafarga; A Muñoz Journal: J Cell Biol Date: 2001-07-23 Impact factor: 10.539
Authors: Jan B Egan; Patricia A Thompson; Milen V Vitanov; Leonid Bartik; Elizabeth T Jacobs; Mark R Haussler; Eugene W Gerner; Peter W Jurutka Journal: Mol Carcinog Date: 2010-04 Impact factor: 4.784
Authors: Hassan Ashktorab; Bijou Nguza; Mehrnaz Fatemi; Mehdi Nouraie; Duane T Smoot; Alejandro A Schäffer; Sonia S Kupfer; Carlos A Camargo; Hassan Brim Journal: PLoS One Date: 2011-10-13 Impact factor: 3.240
Authors: Sonia S Kupfer; Jeffrey R Anderson; Anton E Ludvik; Stanley Hooker; Andrew Skol; Rick A Kittles; Temitope O Keku; Robert S Sandler; Clara Ruiz-Ponte; Sergi Castellvi-Bel; Antoni Castells; Angel Carracedo; Nathan A Ellis Journal: PLoS One Date: 2011-10-27 Impact factor: 3.240